Abstract
Because one excludes in the sequential parallel comparison design (SPCD) both placebo responders and patients assigned to the experimental treatment in period 1 from comparison in period 2, test procedures for the SPCD may lose efficiency. Assuming a random effects logistic regression model, we evaluate the loss of efficiency by comparing power of the SPCD with those for the parallel groups design with repeated measurements (PGDRM), simple crossover design (SCD), and parallel group design (PGD). Based on Monte Carlo simulations, we find that the increase in efficiency of the SPCD by use of the PGDRM and SCD can be significant, especially when the variation of responses between patients is large. The SPCD can be, however, of use if the relative treatment effect on placebo non-responders is of our primary interest.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Communications in Statistics - Simulation and Computation
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
